SEC Form D filing

NewcelX Ltd.

Biotech · Series A · Regulation D 506(b) · Filed May 12, 2026

Offering amount
$3.4M
Exemption
Reg D 506(b)
Issuer state
Not disclosed
Filing date
May 12, 2026
Signature date
—
CIK
0001783036

Summary

NewcelX suggests cellular/life sciences innovation; $3.4M offering consistent with biotech series-a.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.